10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 71,905 | 75,289 | 61,207 | 55,819 | 53,578 |
| Cost of Goods | 15,108 | 16,582 | 15,480 | 15,006 | 13,965 |
| Gross Profit | 56,797 | 58,707 | 45,727 | 40,813 | 39,613 |
| Operating Expenses | 76,789 | 67,369 | 55,303 | 51,181 | 43,613 |
| Operating Income | -19,884 | -8,080 | -9,096 | -10,362 | -3,035 |
| Interest Expense | 662 | 992 | 708 | 695 | 684 |
| Other Income | -299 | 2,046 | 209 | 247 | 117 |
| Pre-tax Income | -20,845 | -7,026 | -9,595 | -10,810 | -3,602 |
| Income Tax | 298 | 108 | 8 | 68 | 34 |
| Net Income Continuous | -21,143 | -7,134 | -9,603 | -10,878 | -3,636 |
| Net Income | $-21,143 | $-7,134 | $-9,603 | $-10,878 | $-3,636 |
| EPS Basic Total Ops | -0.22 | -0.07 | -0.33 | -0.70 | -0.25 |
| EPS Basic Continuous Ops | -0.22 | -0.07 | -0.33 | -0.70 | -0.25 |
| EPS Diluted Total Ops | -0.22 | -0.07 | -0.33 | -0.70 | -0.25 |
| EPS Diluted Continuous Ops | -0.22 | -0.07 | -0.33 | -0.70 | -0.25 |
| EBITDA(a) | $-15,624 | $-5,235 | $-7,055 | $-9,218 | $-1,999 |